Oncology & Cancer

Drug reprograms immune responses to target glioblastoma

Investigators from Northwestern University Feinberg School of Medicine and The University of Texas MD Anderson Cancer Center have discovered that using a novel drug to target the STING pathway in glioblastoma reprogrammed ...

Neuroscience

How immunity contributes to aging and neurodegeneration

As we age, our bodies undergo various changes that can impact our overall health and make us more susceptible to diseases. One common factor in the aging process is low-grade inflammation, which contributes to age-related ...

page 1 from 6